Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 122

1.

Rationale and design of the GISSI heart failure trial: a large trial to assess the effects of n-3 polyunsaturated fatty acids and rosuvastatin in symptomatic congestive heart failure.

Tavazzi L, Tognoni G, Franzosi MG, Latini R, Maggioni AP, Marchioli R, Nicolosi GL, Porcu M; GISSI-HF Investigators..

Eur J Heart Fail. 2004 Aug;6(5):635-41.

2.

Effect of n-3 polyunsaturated fatty acids and rosuvastatin in patients with heart failure: results of the GISSI-HF trial.

Marchioli R, Levantesi G, Silletta MG, Barlera S, Bernardinangeli M, Carbonieri E, Cosmi F, Franzosi MG, Latini R, Lucci D, Maggioni AP, Moretti L, Nicolosi GL, Porcu M, Rossi MG, Tognoni G, Tavazzi L; GISSI-HF Investigators..

Expert Rev Cardiovasc Ther. 2009 Jul;7(7):735-48. doi: 10.1586/erc.09.70.

PMID:
19589110
3.

[The GISSI-HF trial].

Tavazzi L, Nodari S.

G Ital Cardiol (Rome). 2009 Mar;10(3):129-34. Italian. No abstract available.

PMID:
19385306
4.

Controlled Rosuvastatin Multinational Trial In Heart Failure (the positive negative trial).

Serebruany VL.

Am J Cardiol. 2008 Jun 15;101(12):1808-9. doi: 10.1016/j.amjcard.2008.02.084. Epub 2008 Apr 9. No abstract available.

PMID:
18549865
5.

Effects of rosuvastatin on atrial fibrillation occurrence: ancillary results of the GISSI-HF trial.

Maggioni AP, Fabbri G, Lucci D, Marchioli R, Franzosi MG, Latini R, Nicolosi GL, Porcu M, Cosmi F, Stefanelli S, Tognoni G, Tavazzi L; GISSI-HF Investigators..

Eur Heart J. 2009 Oct;30(19):2327-36. doi: 10.1093/eurheartj/ehp357. Epub 2009 Aug 30.

PMID:
19717850
6.

[Rosuvastatin in patients with chronic heart failure].

Hoppe UC, Nitschmann S.

Internist (Berl). 2009 Apr;50(4):501-2. doi: 10.1007/s00108-009-2360-8. German. No abstract available.

PMID:
19300974
7.

Effects of n-3 polyunsaturated fatty acids and of rosuvastatin on left ventricular function in chronic heart failure: a substudy of GISSI-HF trial.

Ghio S, Scelsi L, Latini R, Masson S, Eleuteri E, Palvarini M, Vriz O, Pasotti M, Gorini M, Marchioli R, Maggioni A, Tavazzi L; GISSI-HF investigators..

Eur J Heart Fail. 2010 Dec;12(12):1345-53. doi: 10.1093/eurjhf/hfq172. Epub 2010 Oct 16. Erratum in: Eur J Heart Fail. 2011 Sep;13(9):1042.

8.

Atorvastatin, not rosuvastatin, improves cardiac function in heart failure: a meta-analysis of randomized trials.

Takagi H, Umemoto T.

Int J Cardiol. 2012 Mar 8;155(2):296-9. doi: 10.1016/j.ijcard.2011.11.079. Epub 2011 Dec 24. No abstract available.

PMID:
22200185
9.

[Statin therapy for systolic heart failure. The CORONA trial (Controlled Rosuvastatin Multinational Trial in Heart Failure)].

Angermann CE, Nitschmann S.

Internist (Berl). 2008 Jul;49(7):884-6. doi: 10.1007/s00108-008-2124-x. German. No abstract available.

PMID:
18427760
10.

Beyond coronary artery disease: rosuvastatin in older patients with ischemic systolic heart failure.

Capurso C, Solfrizzi V, D'Introno A, Colacicco AM, Gadaleta A, Frisardi V, Santamato A, Capurso A, Panza F.

J Am Geriatr Soc. 2008 Jul;56(7):1366-7. doi: 10.1111/j.1532-5415.2008.01727.x. No abstract available.

PMID:
18774975
11.

Response to Letter Regarding Article, "Risk of Stroke in Chronic Heart Failure Patients Without Atrial Fibrillation: Analysis of the Controlled Rosuvastatin in Multinational Trial Heart Failure (CORONA) and the Gruppo Italiano per lo Studio della Sopravvivenza nell'Insufficienza Cardiaca-Heart Failure (GISSI-HF) Trials.".

Abdul-Rahim AH, Perez AC, Fulton RL, Jhund PS, Latini R, Tognoni G, Wikstrand J, Kjekshus J, Lip GY, Maggioni AP, Tavazzi L, Lees KR, McMurray JJ.

Circulation. 2015 Dec 1;132(22):e358. doi: 10.1161/CIRCULATIONAHA.115.018395. No abstract available.

12.

[The role of statins in the treatment of heart failure].

Eren M.

Turk Kardiyol Dern Ars. 2009 Oct;37(7):501-11. Review. Turkish.

13.

[Rosuvastatin has no effect on clinical outcomes in patients with heart failure. Results of the GISSI-HF trial].

Preorazhenskiń≠ DV.

Kardiologiia. 2009;49(4):64-5. Russian. No abstract available.

PMID:
19463122
15.

Rosuvastatin and cardiovascular continuum when time is important.

Barrios V, Escobar C.

J Am Coll Cardiol. 2010 Apr 13;55(15):1645-6; author reply 1646. doi: 10.1016/j.jacc.2009.12.031. No abstract available.

16.

CORONA--rosuvastatin in older patients with systolic heart failure.

Jackson G.

Int J Clin Pract. 2008 Jan;62(1):1. doi: 10.1111/j.1742-1241.2007.01663.x. No abstract available.

PMID:
18173807
17.

Risk of Stroke in Chronic Heart Failure Patients Without Atrial Fibrillation: Analysis of the Controlled Rosuvastatin in Multinational Trial Heart Failure (CORONA) and the Gruppo Italiano per lo Studio della Sopravvivenza nell'Insufficienza Cardiaca-Heart Failure (GISSI-HF) Trials.

Abdul-Rahim AH, Perez AC, Fulton RL, Jhund PS, Latini R, Tognoni G, Wikstrand J, Kjekshus J, Lip GY, Maggioni AP, Tavazzi L, Lees KR, McMurray JJ; Investigators of the Controlled Rosuvastatin Multinational Study in Heart Failure (CORONA).; GISSI-Heart Failure (GISSI-HF) Committees and Investigators..

Circulation. 2015 Apr 28;131(17):1486-94; discussion 1494. doi: 10.1161/CIRCULATIONAHA.114.013760. Epub 2015 Mar 25.

18.

Going for gold, from Beijing to Munich, highlights from the ESC 2008 Congress: BEAUTIFUL, GISSI-HF, and potential new therapies for acute decompensated heart failure.

Kalra P, Pauriah M, Elder D, Lang CC.

Cardiovasc Ther. 2008 Winter;26(4):235-7. doi: 10.1111/j.1755-5922.2008.00061.x. No abstract available.

PMID:
19035873
19.

Plasma concentration of amino-terminal pro-brain natriuretic peptide in chronic heart failure: prediction of cardiovascular events and interaction with the effects of rosuvastatin: a report from CORONA (Controlled Rosuvastatin Multinational Trial in Heart Failure).

Cleland JG, McMurray JJ, Kjekshus J, Cornel JH, Dunselman P, Fonseca C, Hjalmarson A, Korewicki J, Lindberg M, Ranjith N, van Veldhuisen DJ, Waagstein F, Wedel H, Wikstrand J; CORONA Study Group..

J Am Coll Cardiol. 2009 Nov 10;54(20):1850-9. doi: 10.1016/j.jacc.2009.06.041.

20.

Effect of rosuvastatin monotherapy and in combination with fenofibrate or omega-3 fatty acids on serum vitamin D levels.

Makariou SE, Liberopoulos EN, Agouridis AP, Challa A, Elisaf M.

J Cardiovasc Pharmacol Ther. 2012 Dec;17(4):382-6. doi: 10.1177/1074248412439470. Epub 2012 Mar 19.

PMID:
22431864

Supplemental Content

Support Center